|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
Resapp Health (RAP.AX)
Trading: SELL @ $0.17
Signal Strength: MEDIUM
Resapp Health (ASX:RAP) current distribution has given weakness to the share price and the continuation of bearish trading conditions. Currently, the ADLINE is -792947. day. During the quarter, the lowest ADLINE value was -792947.
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading exit. Indicator can be applied to the short/medium term timeframe, but the best results are obtained with larger cyclical swings in-line with the trend direction. This accumulation / distribution oscillator can provide guidance on the money flow direction from the companies recent trading.
Accumulation/distribution (ADLINE) is a momentum indicator that attempts to gauge supply and demand by determining whether investors are generally accumulating or buying or distributing or selling a certain stock by identifying divergences between stock price and volume flow. The accumulation/distribution is calculated by first calculating the money flow multiplier then multiplying the money flow multiplier by the period’s volume.
Calculation: Accumulation Distribution Line:
1) Money Flow Multiplier = [(close - low) - (high - close)] / (high - low);
2) Money Flow Volume = Money Flow Multiplier x volume for the period;
3) Accumulation/Distribution= previous Accumulation/Distribution + current periods Money Flow Volume.
PROFILE: Resapp Health (RAP.AX)
Stock Exchange: ASX
Company: Resapp Health
Ticker Codes: | RAP.AX | ASX:RAP |
ResApp Health Limited develops and commercializes the ResApp technology to provide health care solutions for respiratory disease. The company offers telehealth companies with point of care diagnostic solutions to integrate into their platforms. It provides SMARTCOUGH-C, a multi-site, double blind, and prospective clinical study to investigate ResAppDx for the diagnosis of respiratory disease in infants and children using cough sounds, as well as the diagnosis of pneumonia, croup, bronchiolitis, asthma/reactive airways disease, lower respiratory tract disease, and upper respiratory tract infection. The company was formerly known as Narhex Life Sciences Limited. ResApp Health Limited was founded in 2014 and is headquartered in Brisbane, Australia.
|AJX Alexium International||0.06||14||224,969||-187,594.8||BEARISH|
|MNS Milnes Holdings||0.08||7.1||959,142||-98,713.2||BEARISH|
|ALK Alkane Exploration||0.91||6.5||4,762,492||-1,084,175.2||BEARISH|
|RFG Retail Food||0.1||5.4||3,641,364||-1,650,148.3||BEARISH|
|FDV Frontier Digital Ventures||1||5.3||159,343||-2,282.9||BEARISH|
|LYC Lynas Corporation||2||5||8,370,794||-1,615,780||BEARISH|
|CGC Consolidated Gaming Corporation||3||4.9||7,402,442||-583,643.1||BEARISH|
|MTO Moto Goldmines||1.68||3.7||0||-694.8||BEARISH|